DaVita stock holds above USD 183 as earnings estimates rise

Published on 09/23/2026 at 11:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DaVita stock closed at USD 183.34 on September 22, 2026, up 61.2 percent year to date. Q2 EPS reached USD 4.02, beating estimates by USD 0.14.

Modernes Dialysezentrum mit Pflegepersonal und Patienten in heller Klinikumgebung — DaVita Inc. Dialysezentrum mit modernen Behandlungsstühlen und medizinischem Pflegepersonal in Denver, ISIN US23918K1088, Illustration mit AI erstellt.

DaVita Inc. (ISIN US23918K1088) closed at USD 183.34 on the NYSE on September 22, 2026, gaining 0.55 percent. The dialysis provider's shares were up 61.2 percent from the start of 2026, while the latest quarterly earnings provided the main fundamental support for the valuation.

Q2 earnings beat estimates

DaVita reported earnings of USD 4.02 per share for the second quarter of 2026, exceeding the consensus estimate of USD 3.88 by USD 0.14, according to MarketBeat on August 4, 2026. Revenue for the quarter increased 5.2 percent from the comparable period, giving investors a measurable improvement on both the top and bottom lines.

The result matters because the stock has already advanced substantially during 2026. A 61.2 percent year-to-date gain leaves less room for disappointment, making the next reported comparison between revenue growth and earnings expansion particularly important.

Valuation follows the rally

MarketBeat listed DaVita at a price-to-earnings ratio of 15.00 on September 23, 2026, below the broader market multiple of about 39.14 cited in the same overview. That valuation gap helps explain why earnings growth remains central to the investment case rather than the share price increase alone.

The average analyst price target stood at USD 233.43 on September 23, 2026, compared with a USD 183.34 reference price. The target was also accompanied by a Moderate Buy consensus, based on four buy ratings and three hold ratings, according to MarketBeat.

Stock remains below yearly high

DaVita traded between USD 101.00 and USD 247.49 over the 52 weeks covered by the September 23, 2026 market snapshot. The latest close was therefore USD 64.15 below the 52-week high and USD 82.34 above the low, placing the stock closer to the upper end of its annual range.

Market capitalization was USD 11.70 billion and reported volume was 529,350 shares in the same snapshot. The combination of a 15.00 earnings multiple, 5.2 percent quarterly revenue growth and USD 4.02 quarterly EPS gives the market a clear set of figures to test when DaVita next reports.

DaVita stock closes at USD 183.34

DaVita stock closed at USD 183.34 on the NYSE on September 22, 2026, with a daily gain of 0.55 percent. The price, market capitalization, 52-week range and volume figures are based on the September 23, 2026 market snapshot.